Skip to content
Keyword
Name
Filter your search:
All
Services & Industries
Experience
Insights
News
Others
Filter your search:
Search All
Services
Experience
Insights
Professionals
Services
Industries
Insights
Trending Topics
About
Locations
Careers
Search
Close
Menu
Close
发表文章
October 16, 2018
Lower Drug Prices Aren't Worth Higher Health Risks
Email
Facebook
LinkedIn
Twitter
Authors:
Libby Baney Burstein
Libby Baney
co-authored an article for
Drug Topics
about the risks of lower cost medicines. The article explained how making medications more affordable could also sacrifice patient safety.
Full Article
作者
Libby Baney Burstein
Partner
Washington, D.C.
+1 202 312 7438
libby.burstein@faegredrinker.com
Related Legal Services
Health Care
Related Policy, Advocacy, and Consulting Services
Health Care & Life Sciences Consulting
Related Industries
Health & Life Sciences
Digital Health
Lower Drug Prices Aren't Worth Higher Health Risks | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=05c30bad7b8d4ea7ad0c651ad1851738&hash=260633C7701BB47FD3D22AB23C3B7A33
Lower Drug Prices Aren't Worth Higher Health Risks | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=05c30bad7b8d4ea7ad0c651ad1851738&hash=260633C7701BB47FD3D22AB23C3B7A33